Taken together, RIPK1/3 and necroptosis play important roles in the pathophysiology of aging-associated cardiovascular disease, targeting necroptosis pathway may provide therapeutic benefit in the treatment of cardiovascular disease. The gene discussed is RIPK1; the disease is cardiovascular disorder.